Skip to main content
RUA LIFE SCIENCES PLC logo

RUA LIFE SCIENCES PLC — Investor Relations & Filings

Ticker · RUA ISIN · GB0033360586 LEI · 213800BMVB22PVOJ9Z28 IL Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2024-09-09 M&A Activity
Country GB United Kingdom
Listing IL RUA

About RUA LIFE SCIENCES PLC

https://rualifesciences.com/

RUA Life Sciences is a medical device group focused on the application of its proprietary long-term implantable polymer, Elast-Eon™, a biostable polyurethane. The company operates through four integrated businesses to develop, manufacture, and license medical device solutions. RUA Biomaterials is responsible for licensing the Elast-Eon™ technology. RUA Medical provides end-to-end contract development and manufacturing services, specializing in implantable fabrics. RUA Vascular develops large-bore, polymer-sealed vascular grafts and soft tissue patches. RUA Structural Heart is engaged in the development of next-generation tri-leaflet polymeric heart valves. The group's collective mission is to improve patient outcomes by enabling and enhancing medical devices through its advanced polymer technology.

Recent filings

Filing Released Lang Actions
Acquisition
M&A Activity Classification · 1% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content details a specific corporate action: the acquisition of Analytic Biosurgical Solutions SAS by RUA Life Sciences PLC. This type of announcement, which is a material event disclosure but not a full periodic report (like 10-K or IR), typically falls under general regulatory announcements. Since it is not a dividend notice (DIV), director dealing (DIRS), capital change (CAP/SHA), or earnings release (ER), the most appropriate general category for a significant, non-standard corporate event announcement distributed via RNS is the Regulatory Filings fallback category (RNS). It is not an announcement of a report publication (RPA) because it contains the substantive news itself, not just a notice that a report is available.
2024-09-09 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Result of AGM' and provides a table detailing the 'Votes For' and 'Votes Against' for several resolutions presented at the Annual General Meeting. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, the core content is the voting outcome, not the AGM presentation materials (AGM-R) or the proxy solicitation (PSI). The document is short and is a formal announcement via RNS.
2024-08-28 English
AGM Statement and Trading Update
Earnings Release Classification · 1% confidence The document is titled "AGM Statement and Trading Update" and explicitly states it is provided to coincide with the Company's Annual General Meeting ("AGM") taking place later that day. It contains a trading update for the four months to 31 July 2024, including revenue figures and outlook. This content—a statement delivered at an AGM that also includes operational/financial updates—fits best under the AGM Information category, as it is directly tied to the meeting proceedings and materials. While it contains trading updates (similar to ER or IR), the context of being an 'AGM Statement' makes AGM-R the most precise classification. H1 2025
2024-08-27 English
New Material Project Win
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated '24 July 2024'. It announces a 'New Material Project Win' and details a contract value, which is a specific operational update. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and source strongly indicate a regulatory news service announcement. Since the content is a specific business update (contract win) and not a general regulatory filing, a dividend notice, or a report publication announcement, the most appropriate category is the general Regulatory Filings fallback (RNS), as it is disseminated via the RNS system for immediate market disclosure.
2024-07-24 English
Final Results
Earnings Release Classification · 1% confidence The document explicitly states it contains the 'Final results for the year ended 31 March 2024' and provides detailed financial highlights (Revenue, Loss before tax, Cash position) and a Chairman's Statement/Business Review. This structure is characteristic of a comprehensive annual financial report. Although it is presented via an RNS announcement (RNS Number: 5542X), the content itself is the full set of audited final results, which aligns best with the Annual Report (10-K) definition, or potentially an Interim/Quarterly Report (IR) if the period was shorter, but 'year ended' confirms it is annual. Since the definition for 10-K is 'Official yearly report covering company activity and full financial performance,' this is the most appropriate classification for the substance of the document, despite the RNS wrapper. FY 2024
2024-07-24 English
Board Changes, Issue of Options and PDMR Dealing
Regulatory Filings Classification · 1% confidence The document is an official announcement released via RNS (RUA Life Sciences Plc, RNS Number: 0577T, dated 19 June 2024). The primary content details an 'Appointment of Non-Executive Chairman & Board Changes' and the 'Issue of Share Options and PDMR Dealing'. The latter part of the document is a formal notification structure required under Article 19(1) of Regulation (EU) No. 596/2014, detailing transactions by Persons Discharging Managerial Responsibilities (PDMRs). Changes in board composition (appointment of a Non-Executive Chairman) and the granting of share options to directors/staff are direct indicators of Board/Management Information (MANG). While it also contains elements of Director's Dealing (DIRS) via the PDMR notification, the overarching theme and initial announcement focus on restructuring the board and management roles, making MANG the most appropriate primary classification for this type of corporate governance update.
2024-06-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.